Showing results (1-10 of 28) with videos related to
Sort By:
Pageof 3
Nihon Rinsho. Japanese Journal of Clinical Medicine|May 21, 2003
[Acute heart failure]Noboru Takekoshi, Takayoshi AsajiExpert Opinion on Investigational Drugs|May 31, 2002
Cholesterol absorption inhibitors in development as potential therapeuticsKouji Kajinami, Noboru TakekoshiCardiovascular Drug Reviews|August 22, 2003
Pitavastatin: efficacy and safety profiles of a novel synthetic HMG-CoA reductase inhibitorKouji Kajinami, Noboru Takekoshi, Yasushi SaitoClinical and Experimental Nephrology|September 6, 2012
The administration of pitavastatin augments creatinine clearance associated with reduction in oxidative stress parameters: acute and early effectsHirokazu Kakuda, Keizo Kanasaki, Daisuke Koya, et al.Journal of Clinical Medicine Research|January 11, 2019
Residual Effect of Sodium Glucose Cotransporter 2 Inhibitor, Tofogliflozin, on Body Weight After Washout in Japanese Men With Type 2 DiabetesHirokazu Kakuda, Junji Kobayashi, Masaru Sakurai, et al.Cholesterol|January 4, 2014
Short-term effect of pitavastatin treatment on glucose and lipid metabolism and oxidative stress in fasting and postprandial state using a test meal in Japanese menHirokazu Kakuda, Junji Kobayashi, Mio Nakato, et al.Atherosclerosis|November 9, 2004
Pharmacogenetics of HMG-CoA reductase inhibitors: exploring the potential for genotype-based individualization of coronary heart disease managementKouji Kajinami, Noboru Takekoshi, Margaret E Brousseau, et al.The Japanese Journal of Physiology|October 8, 2003
Differential activation of protein kinase C between ischemic and pharmacological preconditioning in the rabbit heartShinji Okubo, Yujirou Tanabe, Nakaba Fujioka, et al.Scandinavian Journal of Clinical and Laboratory Investigation|February 26, 2014
Comparison of atorvastatin, pitavastatin and rosuvastatin for residual cardiovascular risk using non-fasting blood samplingHirokazu Kakuda, Munetoshi Matoba, Hideaki Nakatoh, et al.Journal of Clinical Medicine Research|April 11, 2017
The Effect of Tofogliflozin Treatment on Postprandial Glucose and Lipid Metabolism in Japanese Men With Type 2 Diabetes: A Pilot StudyHirokazu Kakuda, Junji Kobayashi, Masaru Sakurai, et al.Pageof 3